SCHEMBL609310

SCHEMBL609310

O=C(/C=C(O)/C=C/c1cccc(O)c1)/C=C/c1cccc(O)c1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FOS P01100 2/20 0.68
JUN P05412 2/20 0.68
GSK3B P49841 4/20 0.64
BACE1 P56817 4/20 0.64
TLR9 Q9NR96 1/20 0.64
MGAM O43451 1/20 0.60
GAA P10253 1/20 0.60
SI P14410 1/20 0.60
MGAM2 Q2M2H8 1/20 0.60
MMP1 P03956 4/20 0.56
MMP2 P08253 4/20 0.56
MMP9 P14780 4/20 0.56
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
HSP90AA1 P07900 1/20 0.54
P4HB P07237 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL609311 1.00 FOS (0.68) FOSJUNGSK3BBACE1TLR9
SCHEMBL667568 0.87 CYP2C9 (0.63) MGAMGAASIMGAM2MMP1
SCHEMBL667567 0.87 CYP2C9 (0.63) MGAMGAASIMGAM2MMP1
SCHEMBL10021655 0.86 CYP2C9 (0.70) MGAMGAASIMGAM2MMP1
SCHEMBL10021666 0.82 LCK (0.71) MGAMGAASIMGAM2MMP1
SCHEMBL10504122 0.82 NPSR1 (0.65) MMP1MMP2MMP9MAOAMAOB
SCHEMBL448904 0.82 NPSR1 (0.65) MMP1MMP2MMP9MAOAMAOB
SCHEMBL442408 0.82 NPSR1 (0.65) MMP1MMP2MMP9MAOAMAOB
SCHEMBL29405719 0.82 NPSR1 (0.65) MMP1MMP2MMP9MAOAMAOB
SCHEMBL4554034 0.81 FOS (0.61) FOSJUNGSK3BBACE1TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11596716-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2023-03-07 US disclosed
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2021-05-13 US disclosed
US-10874766-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2020-12-29 US disclosed
EP-3038621-B1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RES INSTITUTE (US) 2020-12-02 EP disclosed
EP-3038621-A2 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR Human Biomolecular Research Institute (US) 2016-07-06 EP disclosed
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2016-02-11 US disclosed
WO-2014146039-A2 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2014-09-18 WO disclosed
US-20120040976-A1 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2012-02-16 US disclosed
US-20120040976-A1 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2012-02-16 US disclosed
US-20120040976-A1 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2012-02-16 US disclosed
WO-2010068935-A2 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2010-06-17 WO disclosed
US-20090263492-A1 Diagnostic Methods and Genetic Markers for Alzheimer Disease HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2009-10-22 US disclosed
WO-2008048410-A9 DIAGNOSTIC METHODS AND GENETIC MARKERS FOR ALZHEIMER DISEASE HUMAN BIOMOLECULAR RES INST (US) 2008-06-26 WO disclosed
WO-2008048410-A2 DIAGNOSTIC METHODS AND GENETIC MARKERS FOR ALZHEIMER DISEASE HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2008-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10874766-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 FOS 470/4885JUN 2257/4885GSK3B 920/4885
US-11596716-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 FOS 308/4885JUN 1770/4885GSK3B 918/4885
US-20090263492-A1 Diagnostic Methods and Genetic Markers for Alzheimer Disease CHAT, SLC18A3, GAP43 FOS 4099/4885JUN 4432/4885GSK3B 2770/4885
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 FOS 308/4885JUN 1770/4885GSK3B 918/4885
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 FOS 465/4885JUN 2775/4885GSK3B 998/4885
US-20120040976-A1 SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE L1CAM, LY96, GMFG FOS 4116/4885JUN 4222/4885GSK3B 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.